Brief: Allergy Therapeutics HY Revenue 18% Lower At £39.9M
June 19 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS PLC - REVENUE FOR FIRST HALF OF
FINANCIAL
YEAR WAS 18% LOWER AT £39.9M
* ALLERGY THERAPEUTICS PLC - HY GROSS PROFIT DECREASED BY
28% TO
£25.8M
* ALLERGY THERAPEUTICS PLC - EXPECTS SALES FOR SECOND HALF
YEAR TO
30 JUNE 2023 TO CONTINUE AT A SLIGHTLY IMPROVED TREND
Source text for Eikon: ID:nRSS0740Da
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update